240 related articles for article (PubMed ID: 33323766)
21. Is cotrimoxazole prophylaxis against Pneumocystis jirovecii pneumonia needed in patients with systemic autoimmune rheumatic diseases requiring immunosuppressive therapies?
Pereda CA; Nishishinya-Aquino MB; Brito-García N; Díaz Del Campo Fontecha P; Rua-Figueroa I
Rheumatol Int; 2021 Aug; 41(8):1419-1427. PubMed ID: 33656582
[TBL] [Abstract][Full Text] [Related]
22. Pneumocystis jirovecii pneumonia 13 years post renal transplant following a recurrent cytomegalovirus infection.
Muhammad Iqbal AH; Lim SK; Ng KP; Tan LP; Chong YB; Keng TC
Transpl Infect Dis; 2012 Aug; 14(4):E23-6. PubMed ID: 22551151
[TBL] [Abstract][Full Text] [Related]
23. No recurrence of Pneumocystis jirovecii Pneumonia after solid organ transplantation regardless of secondary prophylaxis.
Kim T; Sung H; Lee YM; Hong HL; Kim SH; Choi SH; Woo JH; Kim YS; Lee SO
Antimicrob Agents Chemother; 2012 Nov; 56(11):6041-3. PubMed ID: 22948875
[TBL] [Abstract][Full Text] [Related]
24. Discontinuing Pneumocystis jirovecii Pneumonia Prophylaxis in HIV-Infected Patients With a CD4 Cell Count <200 cells/mm3.
Sidhu VK; Foisy MM; Hughes CA
Ann Pharmacother; 2015 Dec; 49(12):1343-8. PubMed ID: 26358129
[TBL] [Abstract][Full Text] [Related]
25. An outbreak of Pneumocytis jirovecii pneumonia among liver transplant recipients.
Miguel Montanes R; Elkrief L; Hajage D; Houssel P; Fantin B; Francoz C; Dreyfuss D; Ricard JD; Durand F
Transpl Infect Dis; 2018 Oct; 20(5):e12956. PubMed ID: 29896781
[TBL] [Abstract][Full Text] [Related]
26. Incidence, risk factors, and clinical outcomes of HBV reactivation in non-liver solid organ transplant recipients with resolved HBV infection: A systematic review and meta-analysis.
Yin S; Zhang F; Wu J; Lin T; Wang X
PLoS Med; 2023 Mar; 20(3):e1004196. PubMed ID: 36920988
[TBL] [Abstract][Full Text] [Related]
27. Cytomegaloviral or
Sun YS; Huang DF; Lin FC; Hsu CK; Sun IT; Chang SC; Tsai CY; Lai CC
J Rheumatol; 2019 Mar; 46(3):251-258. PubMed ID: 30504509
[TBL] [Abstract][Full Text] [Related]
28. Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience.
Mecoli CA; Saylor D; Gelber AC; Christopher-Stine L
Clin Exp Rheumatol; 2017; 35(4):671-673. PubMed ID: 28134084
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
[TBL] [Abstract][Full Text] [Related]
30. Incidence of Pneumocystis jirovecii and Adverse Events Associated With Pneumocystis Prophylaxis in Children Receiving Glucocorticoids.
Basiaga ML; Ross ME; Gerber JS; Ogdie A
J Pediatric Infect Dis Soc; 2018 Dec; 7(4):283-289. PubMed ID: 28992298
[TBL] [Abstract][Full Text] [Related]
31. Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis.
Iriart X; Challan Belval T; Fillaux J; Esposito L; Lavergne RA; Cardeau-Desangles I; Roques O; Del Bello A; Cointault O; Lavayssière L; Chauvin P; Menard S; Magnaval JF; Cassaing S; Rostaing L; Kamar N; Berry A
Am J Transplant; 2015 Jan; 15(1):190-9. PubMed ID: 25496195
[TBL] [Abstract][Full Text] [Related]
32. Post-transplant Pneumocystis jirovecii pneumonia--a re-emerged public health problem?
Chapman JR; Marriott DJ; Chen SC; MacDonald PS
Kidney Int; 2013 Aug; 84(2):240-3. PubMed ID: 23739237
[TBL] [Abstract][Full Text] [Related]
33. Critical appraisal of the quality and content of clinical practice guidelines for pneumocystis jiroveci pneumonia (PJP) prophylaxis using the AGREE II instrument.
Yu Y; Yang H; Yu X; Hu X; Wang W; Yang X; Liu H; Ren L; Zhang X; Feng X; Liu L
J Clin Pharm Ther; 2020 Dec; 45(6):1325-1333. PubMed ID: 32710453
[TBL] [Abstract][Full Text] [Related]
34. Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study.
Yu Q; Jia P; Su L; Zhao H; Que C
BMC Infect Dis; 2017 Jun; 17(1):392. PubMed ID: 28583135
[TBL] [Abstract][Full Text] [Related]
35. Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing.
Huang L; Xu S; Huang Z; Chen Y; Xu N; Xie B
BMC Pulm Med; 2023 Feb; 23(1):72. PubMed ID: 36829171
[TBL] [Abstract][Full Text] [Related]
36. Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients.
Urbancic KF; Pisasale D; Wight J; Trubiano JA
Transpl Infect Dis; 2018 Dec; 20(6):e12968. PubMed ID: 30030892
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients.
Lee SH; Huh KH; Joo DJ; Kim MS; Kim SI; Lee J; Park MS; Kim YS; Kim SK; Chang J; Kim YS; Kim SY
Sci Rep; 2017 May; 7(1):1571. PubMed ID: 28484270
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis.
de Boer MG; Kroon FP; le Cessie S; de Fijter JW; van Dissel JT
Transpl Infect Dis; 2011 Dec; 13(6):559-69. PubMed ID: 21689251
[TBL] [Abstract][Full Text] [Related]
39. Late-onset Pneumocystis jirovecii pneumonia in solid organ transplant recipients.
Perez-Ordoño L; Hoyo I; Sanclemente G; Ricart MJ; Cofan F; Perez-Villa F; de la Bellacasa JP; Moreno A; Cervera C
Transpl Infect Dis; 2014 Apr; 16(2):324-8. PubMed ID: 24456244
[TBL] [Abstract][Full Text] [Related]
40. The impact of cytomegalovirus infection on clinical severity and outcomes in kidney transplant recipients with Pneumocystis jirovecii pneumonia.
Lee S; Park Y; Kim SG; Ko EJ; Chung BH; Yang CW
Microbiol Immunol; 2020 May; 64(5):356-365. PubMed ID: 31994768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
